Shakil Ian 4
4 · Augmedix, Inc. · Filed Apr 16, 2024
Insider Transaction Report
Form 4
Augmedix, Inc.AUGX
Shakil Ian
DirectorChief Strategy Officer
Transactions
- Exercise/Conversion
Common Stock
2024-04-15$0.86/sh+500$430→ 3,500 total - Sale
Common Stock
2024-04-15$3.80/sh−500$1,900→ 3,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-04-15−500→ 455,949 totalExercise: $0.86Exp: 2028-12-05→ Common Stock (500 underlying)
Footnotes (2)
- [F1]This transaction was executed pursuant to a Rule 10b5-1 trading plan.
- [F2]Fully vested.